NICE has approved bevacizumab with chemotherapy for untreated metastatic colorectal cancer, citing improved survival and better value from biosimilars.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/biosimilars-tip-nice-decision-bowel-cancer-drug-2025a10010bb?src=rss
Author :
Publish date : 2025-12-24 14:12:00
Copyright for syndicated content belongs to the linked Source.